- Activities: Advancements in the Management of Relapsed/Refractory B-Cell Malignancies Integrating Recent Data into Practice to Improve Outcomes , All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Advancing Cervical Cancer Care: Navigating New Therapies, Guidelines, and Patient-Centric Approaches, Emergency Care of Patients with Cancer Receiving Immunotherapy Experiencing CRS, ICANS, And Other Serious Adverse Events, The Promise of Folate Receptor Alpha-Targeting ADCs for Platinum-Resistant Ovarian Cancer, All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma, All Hands on Deck Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches, Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer, All Hands on Deck: Spotlight on Clinical Advances in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team, Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer, All Hands on Deck Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches, Advancements in the Management of Relapsed/Refractory B-Cell Malignancies Integrating Recent Data into Practice to Improve Outcomes, 6th Annual EGFR Resisters Research Summit, All Hands on Deck: A Focus on Current and Emerging Treatment Options in the Frontline Setting for Peripheral T-cell Lymphoma, Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team, All Hands on Deck Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches, All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives, Navigating New Waters for Advanced or Recurrent Endometrial Cancer, GRE-001, ADCs in HR+/HER2- mBC: Managing AEs, ADCs in HR+/HER2- mBC: Clinical Trial and Real-world Data, Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer, Transforming Metastatic Breast Cancer Management: Harnessing the Power of Antibody-Drug Conjugate Therapies, The Ever-Changing Options for the Treatment of CLL
- Provider Address: Radnor, PA, USA
- Activity Link: http://www.ceconcepts.com
- Number of Activities Reported Last Year: 74
- Name of Contact: Marie Judkins
- Phone Number: (859) 260-1717
- Address: 201 King of Prussia Rd, Suite 370, Radnor, PA, 19087, USA
- Accreditation Status: Joint Accreditation with Commendation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply